View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
December 1, 2021

Siemens software has vulnerabilities that put some crucial medical devices at risk

Software by Siemens could negatively affect the safety of some medical devices and this is why companies should research and monitor existing and new technologies.

By GlobalData

The public becomes more aware of software and hardware vulnerabilities in various medical devices, as the healthcare industry rushes to adopt new technologies to help alleviate the effects of the Covid-19 pandemic and help to sustain the virus. Previously, the F ood and Drug Administration (F DA) has been seeking additional legislative authority in order to have the critical information about the cybersecurity of devices, and ensure that med techs are required to have a Software Bill of Materials (SBOM). F urthermore, several reports have been published in order to increase cybersecurity awareness in healthcare institutions.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

In November 2021, the US Cybersecurity and Infrastructure Security Agency issued an alert concerning critical vulnerabilities in Siemens ’ software, which has the potential to affect how some medical devices such as anaesthesia machines, ventilators and bedside monitors operate. While no attacks have been recorded to target these specific vulnerabilities, if hackers exploit these vulnerabilities, patients’ healthcare will be put at risk. While Siemens has released patches and updates for products that were affected and confirmed that it is further investigating if any more of its products are affected, this news raises yet another concern about cybersecurity issues in medical devices.

The above-mentioned software was released in 1993 and its vulnerabilities raise concerns about using older medical devices. The rate of cyberattacks on healthcare institutions has been steadily increasing since the beginning of the Covid-19 pandemic and they are expected to grow in the future as the healthcare industry adopts more advanced medical devices and increases data collection. Healthcare companies should not only monitor and test the safety of hardware and software of new medical devices but keep updating and monitoring the ones that have been on the medical market for some time.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Related Report
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network